Ethical questions about biomarkers of ageing the view of geriatrics

Similar documents
Nutritional concerns of overweight / obese older persons. Gordon L Jensen, MD, PhD Dept Nutritional Sciences Penn State University

Clinical Treatment of Obesity in Older Women. Barbara Nicklas J. Paul Sticht Center on Aging

The Industry s Views on Older Old Patients

Living well with frailty. JOHN YOUNG National Clinical Director for the Frail Elderly & Integration, NHS England

Statins in the elderly : Is there a rationale?

Chairs: John Lainchbury & Andrew Aitken. Elderly/Frailty

Nutrition and aging: A challenge to health care policy

The Geriatrician in the Trauma Service. Trauma Quality Improvement Program (TQIP) Annual Scientific Meeting and Training 2013

Frailty. Nicholas Butler MD, MBA Department of Family Medicine University of Iowa

Polymedication in nursing home. Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Services for Frailty or Services for Dementia? Dr Gill Turner Lymington New Forest

Chronic Conditions The need for a comprehensive public health approach

The Impact of Smoking on Acute Ischemic Stroke

Geriatrics and Cancer Care

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

Mechanism: How ADT accelerates CVD?

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Sedentary Death Syndrome (SeDS)

Heart Failure and COPD: Common Partners, Common Problems. Nat Hawkins Liverpool Heart and Chest Hospital

Preventive Cardiology Scientific evidence

Biomarkers and undiagnosed disease

Older people are living longer than before, but are they living healthier?

Healthy Ageing. 12 years of results from the Australian Longitudinal Study on Women s Health (ALSWH) Professor Julie Byles

Health Outcome Prioritization as a Tool for Decision Making Among Older Persons With Multiple Chronic Conditions

Frailty and Cognitive Dysfunction in Heart Failure. Disclosures. Frailty 5/24/2017. I have no disclosures relevant to this presentation

The Danish National Research Foundation s Centre of Inflammation and Metabolism Rigshospitalet and University of Copenhagen

End of life. care planning. in dementia. Dr Victor Pace St Christopher s Hospice February 2018

CVD Prevention, Who to Consider

Frailty in Older Adults. Frailty

Care of older people in surgery (COPS)

Ageing as a game-changer for acute and general medicine and wider systems in which we practice

Lauren Griffith McMaster University

Exercise is Medicine: Writing the Prescription for Older Adults

Attributable risk of functional measures

Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s

Cardiac Rehabilitation after Primary Coronary Intervention CONTRA

The patient with multiple chronic conditions: balancing guidelines and patient preference

Presenter Disclosure

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

Public Health and Nutrition in Older Adults. Patricia P. Barry, MD, MPH Merck Institute of Aging & Health and George Washington University

Frailty Predicts Recurrent but Not Single Falls 10 Years Later in HIV+ and HIV- Women

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

Palliative Care and Hospice. Silver Linings: Reflecting on Our Past & Transitioning into our Future

No relevant financial relationships

Population Division, DESA, United Nations: World Population Ageing

End of Life Care in Dementia. Dr Rosie Lockwood Consultant Geriatrician Sheffield Teaching Hospitals

Trial clinici nell anziano: efficacy or effectiveness?

Multimorbidity and systematic reviews

Effects of whole grain intake on weight changes, diabetes, and cardiovascular Disease

Introduction to HIV and Aging

HIV, Multimorbidity, and Frailty: what s going on? (with apologies to Marvin Gaye)

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Nutrition to prevent and treat sarcopenia in older people

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

Brain Health and Risk Factors for Dementia

Biological theory for the construct of intrinsic capacity to be used in clinical settings Matteo Cesari, MD, PhD

Evaluation of fragility and factors influencing falls in nursing homes. Dr Marie-Laure Seux Geriatrics Broca Hospital May 2013

Sarcopenia - a Regulatory Perspective

4.4 - GSF Clinical Skills Training Programme

Low ALT Levels Independently Associated with 22-Year All-Cause Mortality Among Coronary Heart Disease Patients

Sarcopenia and Frailty in Older People

Test & Treat : Changing the face of insurance for persons living with HIV?

Ageing Well. Avoiding falls in older people. Prof Martin Vernon NCD Older People. Find Recognise Assess Intervene Long-term.

FRAILTY SYNDROME. dr. Rose Dinda Martini, Sp.PD, K-Ger

ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS

ORIGINAL INVESTIGATION. Effects of Prehypertension on Admissions and Deaths

The role of medication in falls risk

Hypertension Update Clinical Controversies Regarding Age and Race

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Western University of Health Sciences, College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of

Estrogens vs Testosterone for cardiovascular health and longevity

Working Paper Distribution and types of multiple chronic conditions in Korea. Young-Ho Jung, Sukja Ko

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

Drug use in long term care. Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome

Hypertension Management Controversies in the Elderly Patient

A Snapshot on Aging and Dementia. Changing our minds about people whose minds have changed. G. Allen Power

Faculty/Presenter Disclosure

Hypertension targets in the elderly. Sarah McCracken Consultant Geriatrician North Bristol NHS Trust September 2016

Update on Frailty. Stephanie Studenski Longitudinal Studies Section Intramural Research Program National Institute on Aging

Health and Wellbeing in ELSA

NUTRITION & IMMUNITY IN OLDER AGE

Evolutions in Geriatric Fracture Care Preparing for the Silver Tsunami

Strokes, Falls, Forgetfulness and Frailty Managing the Very Elderly Hypertensive

Changing care systems for people with frailty. John Young

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

CLINICAL OUTCOME Vs SURROGATE MARKER

The Framingham Coronary Heart Disease Risk Score

American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease

Fasting or non fasting?

Has the science of supplementation reached the breakthrough point?

The webinar, Multimorbidity in Canada, will begin shortly.

Hyperlipidemia in an Otherwise Healthy 80 Year-Old Patient. Theodore D Fraker, Jr, MD Professor of Medicine

Supplement materials:

Frailty in Older Adults

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN

public health crisis! Understanding frailty at population level!

Hypertension in the very old. Objectives: Clinical Perspective

Healthcare, hospitals and the challenges of an ageing population

Prescription Fitness. Robert M. Pepper, DO, FAAFP. ACOFP 55th Annual Convention & Scientific Seminars

Transcription:

Ethical questions about biomarkers of ageing the view of geriatrics Biomarker of Ageing Halle 18.-20.09.2009 Manfred Gogol, M.D. Coppenbrügge

Definition Biomarker of Ageing (BMA) are agents that allows to describe a disease earlier maybe used to assess a pre- or sub-clinical state maybe for risk estimation for a disease (far in the future) will let us make better diagnosis will let us make better prognosis will let us make better therapeutic approaches will let us better monitor the patient

Definition BM are agents that allows to describe a diesase earlier maybe a pre-clinical state maybe for risk estimation for a disease (far in the future) will let us make better diagnosis will let us make better prognosis will let us make better therapeutic approaches will let us better monitor the patient Biomarkers are wonderful

Biomarkers are wonderful But most of age-related diseases are not an entity but a syndrome. Furthermore, we have diseases who appear as entity and as syndrome as well.

Age-related disease Syndrome Mixed Entity Falls Dementia Malnutrition Sarcopenia Frailty Incontinence Depression Heart failure Delirium Stroke Osteoporosis Osteoarthritis Diabetes COPD Cancer Macula degeneration CHD Parkinson disease

Single Disease Multimorbidity Functional health

Single Disease co-morbidity Multimorbidity function Functional health

Frailty Fried criteria Weight loss > 5 kg / y Exhauston Muscle weakness Slow walking Low physical activity 3 citeria define Frailty 1-2 criteria define Pre-Frailty

Frailty Fried criteria Weight loss > 5 kg / y Exhauston Muscle weakness Slow walking Low physical activity II Weight loss / Sarcopenia Activity (but look for other conditions too: depression, dementia, other diseases.

Cronic inflammation In basic and clinical research there is a lot of evidence that chronic inflammation play a major (or key) role in cardiovascular disease as in chronic degeneration processes at all

Cronic inflammation? Tsimane population in south america (amazonas) CRP Obesity HDL cholestrol Total cholestrol Active lifestyle Lean diet Gurven M et al. PLoS ONE 2009;4(8):e6590

Hypertension Besides smoking and hyperlipidemia in mid age the key risk factor The only risk factor, where RCTs have shown a benefit in the elderly 80+ In women [similar in men] 75 % of hypertension are preventable by modifying life style risk factors Forman J JAMA 2009 July 22th

Obesity Robert Wood Johnson Foundation 2009

Obesity in children, US 2007 Robert Wood Johnson Foundation 2009

Obesity Europe - Females

Obesity Europe - Male

Diabetes

Intervention post stroke Ischemic stroke Able to walk at discharge n = 314, mean age 69 y, 55 % male Intervention: n = 157 Intervention: detailed training programme to promote physical activity including 5 follow-up visits over 24 month PASE score 69,1 vs 64,0 (95% CI -5,8 15,9, p = 0,36) No effect on mortality, recurrent stroke, myocardial infarction, falls + fractures Boysen G et al. BMJ 2009;339:b2810

Dementia Our possibilities to diagnose Dementia grow by imagine techniques for the brain and also by a various number of biomarkers Our possibilities to predict the conversation from MCI (minimal cognitive impairment) to dementia too

But Dementia II Anti-dementia drugs had no or only a modest effect Controlled trials only about 6 month and with multiple bias factors (nutrition, activity, social support, LOCF method) What is the sense for early diagnosis without a specific therapeutic approach besides general recommendations?

Why I m pessimistic (about BMA) Our (potential) patients usual do only parts (sometimes more, often less) they are told So BMA have a limited function in special situations, special diseases and often add no or less information for clinical decisions Lots of (risk) factors are easy to assess often by phenotype Man are no yeasts (zebrafish etc) the complexity is not only biological, but also psychological / emotional / spiritual / social / ecological

Longevity genes network in yeasts Managbanag JR et al. PLoS ONE 2008;3:e3802

Longevity network in yeasts Protein protein interactions Managbanag JR et al. PLoS ONE 2008;3:e3802

Why I m pessimistic (about BMA) Man are no yeasts (zebrafish etc) the complexity is not only biological, but also psychological / emotional / spiritual / social / ecological I m doubtful about modelling this (potential) circumstances in the lab Depression leads to stress, but stress in yeast doesn t mean the stress of depression in man (and even not the possibilities of life to change this condition)

Health economics (crisis) BMAs for the beginning of the dying process? BMAs for limited life exspectancy?

Why I m optimistic (about BMA) Man has the possibilty for plasticity in all compartiments (body, cognition, emotion, spiritual) not only in the brain

Life exspectancy US 1997 JAMA 2001; 285:2750-6

Effect of training Jerusalem Longitudinal Cohort Study 1990-2008 1.861 persons, 17.109 personyears Examination at age 70, 78, 85 y physical active vs. sedentary participants 8-y-Mortality 70 y: 15,2 vs. 27,2 % (p < 0,001) HR 0,61 8-y-Mortality 78 y: 26,1 vs. 40,8 % (p < 0,001) HR 0,69 3-y-Mortality 85 y: 6,8 vs. 24,4 % (p < 0,001) HR 0,42 Initiating PA 70-78 y: Mortality p = 0,04 Initiating PA 78-85 a: Mortality p < 0,001 Independent ADL [PA]: OR 1,92 (95%CI 1,11-3,33) Stessmann J et al. Arch Intern Med 2009;169:1476-83

Why I m optimistic (about BMA) A growing number of aging or elderly people are healthy ager They can have a benefit BMA will help us in future to make decisions about a therapy or another maybe also to negiotate therapy

Health recommandations BMAs Lots of questions Some answers More questions More answers 1. Physical activity 2. Cognitive activity 3. Healthy nutrition 4. Social relationships 5. Crisis management 6. CV-risk factors 7. Moderate alcohol 8. Think positive and be happy